Meta Biomed Co., Ltd. announces an Equity Buyback for KRW 500 million worth of its shares.
August 05, 2019 at 11:10 pm EDT
Share
Meta Biomed Co., Ltd. (KOSDAQ:A059210) announces a share repurchase program. Under the program, the company will repurchase its own shares for KRW 500 million worth of its shares pursuant to a trust contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on August 5, 2021. As of August 5, 2019, the company had 534,000 shares in treasury within scope available for dividend and had 0 shares in treasury through other repurchase.
Meta Biomed Co., Ltd. is a Korea-based company engaged in the manufacture of medical materials and equipment for biotechnology and dental areas. The Company mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. It also distributes dental-related products.
META BIOMED CO., LTD. 